CClinicalTrials.gg
Not yet recruitingNCT06598904Updated Sep 19, 2024

The Effect of Aromatherapy for First Dental Visit Patients

An interventional study of Aroma diffuser with single-note lavender essential oil and Aroma diffuser with single-note orange essential oil in Dental Anxiety, sponsored by Sichuan University. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by Sichuan University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 6 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

First dental visit experience is strongly correlated with dental anxiety, the aim of this protocol is to explore the efficacy of olfactory aromatherapy for the reduce of dental anxiety and pain in first-visit patient.

02

Conditions studied

  • Dental Anxiety

Browse trials for

Keywords

  • dental anxiety
  • aromatherapy
  • first dental visit
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's planned enrollment of 120 is above the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Sichuan University is the lead sponsor of 106 studies on the registry; 65 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients who never visited dental clinics before;
  • Patients who need dental treatment, such as resin filling, root canal treatment, periodontal initial treatment, tooth extraction, etc;
  • Patients and their guardians who are able to understand the purpose of the study and volunteer to take part in the study;
  • Patients who are intellectually sufficient to complete the anxiety scale;
  • Be able to complete all assessments and follow-up during the study.

Exclusion criteria

Exclusion Criteria:

  • Patients who are allergic to the ingredients of the essential oils used in the experiment or to the materials used in the dental treatment;
  • Patients who underwent only an oral examination;
  • Patients with severe heart disease, hypertension, respiratory disease, or other systemic conditions that were not eligible for trial participation;
  • Pregnant or lactating women;
  • People with depressive symptoms, anxiety disorders or other mental illnesses that affect their mood state;
  • People who are using sedative or analgesic drugs;
  • Recent or current users of essential oils;
  • Any circumstances considered by the investigator to be inappropriate for participation in this study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Group 1: single-note lavender essential oil

    Aroma diffuser with single-note lavender essential oil.

    Other: Aroma diffuser with single-note lavender essential oil

  • Experimental
    Group 2: single-note orange essential oil

    Aroma diffuser with single-note orange essential oil

    Other: Aroma diffuser with single-note orange essential oil

  • Placebo comparator
    Group 3: deionized water

    Aroma diffuser with deionized water.

    Other: Aroma diffuser with deionized water

Interventions

  • OtherAroma diffuser with single-note lavender essential oil

    In a space of 3\*4\*2.6 cubic meters, positioned 10 cm away from the patient, add 4-6 drops (each drop being 0.05 ml) of 100% concentration single-note lavender essential oil into the aroma diffuser reservoir containing 120 ml of water.

  • OtherAroma diffuser with single-note orange essential oil

    In a space of 3\*4\*2.6 cubic meters, positioned 10 cm away from the patient, add 4-6 drops (each drop being 0.05 ml) of 100% concentration single-note orange essential oil into the aroma diffuser reservoir containing 120 ml of water.

  • OtherAroma diffuser with deionized water

    In a space of 3\*4\*2.6 cubic meters, positioned 10 cm away from the patient, add 4-6 drops (each drop being 0.05 ml) of water into the aroma diffuser reservoir containing 120 ml of deionized water.

06

What researchers measure

Primary outcomes

  1. Anxiety scale 1 - Modified Dental Anxiety Scale (MDAS)

    The Modified Dental Anxiety Scale (MDAS) consists of 4 questions each with a 5 category rating scale, ranging from 'not anxious' to 'extremely anxious', hence, the total score varies from 4 to 20, with higher obtained scores describing more elevated levels of dental anxiety. MDAS is recorded before, during and after operation.

    Time frame: 5 minutes before operation/during operation (immediately after the most painful procedure)/immediately after operation.

  2. Pain scale - Visual Analog Scale (VAS)

    The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain." VAS is recorded before, during and after operation.

    Time frame: 5 minutes before operation/during operation (immediately after the most painful procedure)/immediately after operation.

Secondary outcomes

  1. Anxiety scale 2 - State-Trait Anxiety Inventory for State Anxiety (STAI-S)

    The STAI-S evaluates the subjective feelings of tension, worry, nervousness, apprehension, and autonomic nervous system activation. This self-completed inventory consisted of 20 items on a four-point Likert scale running from one (i.e., not at all) to four (i.e., very much). Hence, the total score varies from 20 to 80, with higher obtained scores describing more elevated levels of anxiety. STAI-S is recorded before and after operation.

    Time frame: 5 minutes before operation/ immediately after operation.

  2. Vital sign 1 - systolic blood pressure (SBP)

    Systolic blood pressure (SBP) is measured using a manual sphygmomanometer, before, during and after operation.

    Time frame: 5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.

  3. Vital sign 2 - diastolic blood pressure (DBP)

    Diastolic blood pressure (DBP) is measured using a manual sphygmomanometer, before, during and after operation.

    Time frame: 5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.

  4. Vital sign 3 - heart rate (HR)

    Heart rate (HR) is measured as pulse rate using an oximeter, before, during and after operation.

    Time frame: 5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.

  5. Vital sign 4 - oxygen saturation (SpO2)

    Oxygen saturation (SpO2)is measured using an oximeter, before, during and after operation.

    Time frame: 5 minutes before operation/during operation (immediately after the most painful procedure, and every 10min after)/immediately after operation.

07

Study locations

1 site
  • West China Hospital of Stomatology SIchuan University
    Chengdu, Sichuan 610041, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06598904
Lead sponsor
Sichuan University
Responsible party
He Cai (Post Doctor, Sichuan University) — Principal investigator
First posted
Sep 19, 2024
Start date
Sep 20, 2024 (estimated)
Primary completion
Mar 31, 2025 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Sep 19, 2024

Study contacts

He Cai, MD PhD
Contact
caihe.dr@scu.edu.cn
+86-13281167556

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion